TCT 1050: Atrial flow regulator in patients with severe primary pulmonary arterial hypertension: The AFR PROPHET registry

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Occlutech; Ancora Heart</li><li>Equity/Stock(s)/Options - Bio Refine</li></ul>